title: CANCER. Cancer therapies that are gone with the Wnt.
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, NY 10021, USA. dnanus@med.cornell.edu pag2015@med.cornell.edu.
authors.forename: David M
authors.initials: DM
authors.lastname: Nanus
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, and Meyer Cancer Center, Weill Cornell Medical College, New York, NY 10021, USA. dnanus@med.cornell.edu pag2015@med.cornell.edu.
authors.forename: Paraskevi
authors.initials: P
authors.lastname: Giannakakou
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000818:Animals; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D006801:Humans; D008297:Male; D009360:Neoplastic Cells, Circulating / Q000378:metabolism*; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D011944:Receptors, Androgen / Q000235:genetics*; D051153:Wnt Proteins / Q000378:metabolism*
chemical_list: D000726:Androgen Antagonists; D011944:Receptors, Androgen; D051153:Wnt Proteins; D010669:Phenylthiohydantoin